Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodrigo Fresco

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Therapeutic Advances in Medical Oncology|June 5, 2023
Rationale and trial design of NATALEE: a Phase III trial of adjuvant ribociclib + endocrine therapy Dennis J Slamon, Peter A Fasching, Sara Hurvitz, et al.
The New England Journal of Medicine|March 20, 2024
Ribociclib plus Endocrine Therapy in Early Breast CancerDennis Slamon, Oleg Lipatov, Zbigniew Nowecki, et al.
The Lancet. Oncology|May 1, 2013
Planning cancer control in Latin America and the CaribbeanPaul E Goss, Brittany L Lee, Tanja Badovinac-Crnjevic, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Therapeutic Advances in Medical Oncology|June 5, 2023
Rationale and trial design of NATALEE: a Phase III trial of adjuvant ribociclib + endocrine therapy Dennis J Slamon, Peter A Fasching, Sara Hurvitz, et al.
The New England Journal of Medicine|March 20, 2024
Ribociclib plus Endocrine Therapy in Early Breast CancerDennis Slamon, Oleg Lipatov, Zbigniew Nowecki, et al.
The Lancet. Oncology|May 1, 2013
Planning cancer control in Latin America and the CaribbeanPaul E Goss, Brittany L Lee, Tanja Badovinac-Crnjevic, et al.
Pageof 2